fluvoxamine + omega 3 fatty acid

This is a combination therapy consisting of fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) antidepressant, and omega-3 fatty acids (commonly found in fish oil supplements). Fluvoxamine acts primarily by inhibiting the reuptake of serotonin in the central nervous system, thereby increasing serotonergic activity. Omega-3 fatty acids are polyunsaturated fats with anti-inflammatory properties that may modulate neuronal membrane fluidity and neurotransmitter function. This combination has been studied for its potential to enhance antidepressant effects in patients with major depressive disorder[3][5]. There is no evidence of clinically significant pharmacological interaction between these two agents[1].

Other names

fluvoxamine and omega-3 fatty acidsfluvoxamine plus fish oil